References
- PeuraDAStress-related mucosal damage: an overviewAm J Med1987836A37
- Peivandi YazdiAImantalabMStress-related mucosal disease in critically ill patientsPatient Saf Qual Improv201532266268
- SeslerJMStress-related mucosal disease in the intensive care unit: an update on prophylaxisAACN Adv Crit Care200718211912817473539
- SpirtMJStress-related mucosal disease: risk factors and prophylactic therapyClin Ther200426219721315038943
- MillerTAMechanisms of stress-related mucosal damageAm J Med1987836A8143321980
- PoynardTCalèsPPastaLBeta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study GroupN Engl J Med199132422153215381674104
- HeidelbaughJJInadomiJMMagnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patientsAm J Gastroenterol2006101102200220516952283
- ASHP therapeutic guidelines on stress ulcer prophylaxisASHP Commission on therapeutics and approved by the ASHP Board of Directors on November 14, 1998Am J Health Syst Pharm199956434737910690219
- HanlonJTWeinbergerMSamsaGPA randomized, controlled trial of a clinical Pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacyAm J Med199610044284378610730
- ViktilKKBlixHSThe impact of clinical pharmacists on drug-related problems and clinical outcomesBasic Clin Pharmacol Toxicol2008102327528018248511
- World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human SubjectsBulletin of the World Health Organization2001794
- ICH harmonized tripartite guideline: Guideline for Good Clinical PracticeJ Postgrad Med2001Jan-Mar471455011590294
- GrubeRRMayDBStress ulcer prophylaxis in hospitalized patients not in intensive care unitsAm J Health Syst Pharm200764131396140017592004
- QadeerMARichterJEBrotmanDJHospital-acquired gastrointestinal bleeding outside the critical care unit: risk factors, role of acid suppression, and endoscopy findingsJ Hosp Med200611132017219466
- HeidelbaughJJInadomiJMMagnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patientsAm J Gastroenterol2006101102200220516952283
- NardinoRJVenderRJHerbertPNOveruse of acid-suppressive therapy in hospitalized patientsAm J Gastroenterol200095113118312211095327
- MahmoudiLKaramikhahRMahdaviniaASamieiHPetramfarPNiknamRImplementation of pharmaceutical practice guidelines by a project model based: clinical and economic impactMedicine (Baltimore)20159442e174426496288
- SungJJThe role of acid suppression in the management and prevention of gastrointestinal hemorrhage associated with gastroduodenal ulcersGastroenterol Clin North Am2003323 SupplS11S2314556432
- HeidelbaughJJGoldbergKLInadomiJMOverutilization of proton pump inhibitors: a review of cost-effectiveness and risk [corrected]Am J Gastroenterol2009104Suppl 2S27S3219262544
- BeejayUWolfeMMAcute gastrointestinal bleeding in the intensive care unit. The gastroenterologist’s perspectiveGastroenterol Clin North Am200029230933610836185
- NetzerPGaiaCSandozMEffect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hoursAm J Gastroenterol199994235135710022628
- AllenMEKoppBJErstadBLStress ulcer prophylaxis in the postoperative periodAm J Health Syst Pharm200461658859615061430